- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05673941
"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia (InMotion)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Schizophrenia (SCZ) is among the world's top ten causes of long-term disability (World Health Organization, 2004). The major symptoms of SCZ include hallucinations, delusions, affective flattening, apathy and cognitive impairment. These symptoms lead to major problems in social and occupational functioning, and in self-care.
Our primary aim is to investigate the effects of 12-weeks of physical training with creative movement as an intervention given in addition to ongoing pharmacological treatment, in treating SCZ-symptoms compared to a control group. Secondary aim is to provide results regarding the effects of the intervention on (a) clinical symptom measures and quality of life, (b) levels of physical activity, physical function and measures of general health indicators, (a) clinical symptom measures and quality of life, (b) levels of physical activity, physical function and measures of general health indicators, (c) error detection and conflict resolution on the prefrontal cortex, memory and context processing (d) fluency of speak, and (e) emotional induction and regulation on specific emotions on the frontal cortex. Trough qualitative interviews, we will examine the participants' and their relative parties' experiences from taking part of the intervention and eventual experienced effects from it.
This study, called InMotion, is a prospective randomized controlled trial where the study participants will be randomized to 12-weeks of physical training with creative movement as an intervention in addition to standard care (intervention group) or to standard care alone (control group). The target group consists of adults with SCZ or SCZ-similar condition.
The intervention consists of organized training sessions in group, 2 times a week. The control group receives standard medical care and gets access to the intervention in digital form after the study has ended. The outcomes are measured at baseline, after 6 and 12 weeks, 6 months and 12 months. At all follow-ups, data are collected for both the intervention and control groups. The trial is being conducted in Örebro, Sweden. The study follows the standard methodology of intervention research.
60 patients with SCZ will be recruited continuously by staff at the psychiatry at the university hospital in Örebro. When matched to inclusion and exclusion criteria, written and informed consent will be obtained from all participants willing to participate. 30 patients will be randomized to participate in creative physical training in addition to continuing their conventional treatment plan (SCZ-I group) and 30 patients will be randomized to control group and receive treatment as usual (SCZ-C). Randomization to SCZ-I and SCZ-C groups will be done by sealed envelopes given to the participants after baseline measures.
The intervention covers various themes through three different parts (4 weeks per part). The intervention was developed by a team consisting of physiotherapists, dance teachers, a neuroscientist and a psychiatrist, with the aim to improve clinical symptoms, physical fitness, cognitive skills and emotion regulations. The intervention is further described in Table 1. The exercise is partly accompanied with calm music and recorded nature sounds and partly made in silence listening to one's own bodily rhythm. The exercise consists of tasks related to cardio and strength training, balance, conscious breathing, body awareness, mental imagery (nature visualizations), flexibility, emotional expression, and movement anticipation together with the facilitator and fellow participants. All the tasks are practiced during a flow of 45- to 60-minute exercise without any major breaks. Complexity and physical intensity of the tasks will gradually increase over the 12-week intervention period.
The duration of the biweekly creative movement intervention will be from 45 minutes (week 1 and 2) to 60 minutes (week 3-12), the order and content of which is described in detail in Table 1. Throughout the intervention period, the participants will be encouraged to practice their favorite movements or relaxation techniques at home if they want to. The participants will get recordings of the sessions from the intervention coordinators in the research team, if they want to have support in practicing on their own at home. If a participant misses a session, they will get a text-message and an email with the video again, and encouragement to practice at home to keep up the frequency of two sessions a week, and the instructor will ask them if they have done so to ensure that it is important and relevant with regularity.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Örebro, Sweden, S-70185
- Region Örebro county
-
Örebro, Sweden
- Örebro University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Schizophrenia diagnosis or schizophrenia similar condition, age 18-65 years, performing physical activity less than 150 min/week.
Exclusion Criteria:
- Current or recent history of substance abuse, bipolar disorder, severe autism, suicidal, severe physical illness, inability to read and understand the Swedish language and inability to interact with other people in a group.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Creative movement
The intervention will be performed as a group activity twice a week during a 12-week period.
Each group will include 4-6 participants under the guidance of two instructors, and a related party if needed or wanted from the participant.
The exercise is partly accompanied with calm music and recorded nature sounds and partly made in silence listening to one's own bodily rhythm.
The exercise consists of tasks related to cardio and strength training, balance, conscious breathing, body awareness, mental imagery (nature visualizations), flexibility, emotional expression, and movement anticipation together with the facilitator and fellow participants.
All the tasks are practiced during a flow of 45- to 60-minute exercise without any major breaks.
Complexity and physical intensity of the tasks will gradually increase over the 12-week intervention period.
|
The intervention will be performed as a group activity twice a week during a 12-week period.
Each group will include 4-6 participants under the guidance of two instructors, and a related party if needed or wanted from the participant.
The exercise is partly accompanied with calm music and recorded nature sounds and partly made in silence listening to one's own bodily rhythm.
The exercise consists of tasks related to cardio and strength training, balance, conscious breathing, body awareness, mental imagery (nature visualizations), flexibility, emotional expression, and movement anticipation together with the facilitator and fellow participants.
All the tasks are practiced during a flow of 45- to 60-minute exercise without any major breaks.
Complexity and physical intensity of the tasks will gradually increase over the 12-week intervention period.
|
|
No Intervention: Control group
The control group receives standard medical care and gets access to the intervention in digital form after the study has ended.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive and Negative Syndrome Scale (PANSS)
Time Frame: 45 minutes
|
The Positive and Negative Syndrome Scale (PANSS) is an established psychiatric rating system that is an operationalized, drug-sensitive instrument that offers balanced representation of positive and negative symptoms and estimates their relationship to one another and to global (or general) psychopathology.
|
45 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression - Severity scale (CGI-S)
Time Frame: 2.5 minutes
|
The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis.
|
2.5 minutes
|
|
Clinical Global Impression - Improvement scale (CGI-I)
Time Frame: 2.5 minutes
|
The Clinical Global Impression - Improvement scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.
|
2.5 minutes
|
|
The Calgary Depression Scale for Schizophrenics (CDSS)
Time Frame: 10 minutes
|
The Calgary Depression Scale for Schizophrenia (CDSS) is a nine item clinician rated outcome measure that assesses the level of depression in people with schizophrenia.
|
10 minutes
|
|
Body Awareness Questionnaire (BAQ-sv)
Time Frame: 10 minutes
|
Body Awareness Questionnaire includes 18 suggestions of four subgroups (changes in the body process, sleep-wake cycle, estimation of disease onset, and estimation of body reactions) and aims to determine the level of body awareness.
|
10 minutes
|
|
The personal and social performance scale (PSP)
Time Frame: 10 minutes
|
The Personal Social Performance scale assesses socially useful activities, personal and social relationships, self-care and disturbing and aggressive behaviours.
|
10 minutes
|
|
EQ-5D-5L
Time Frame: 5 minutes
|
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
|
5 minutes
|
|
Burden of Care - Visual Analogue Scale
Time Frame: 5 minutes
|
Burden of Care is rated on a Visual Analogue Scale by a significant other, measuring the expressed burden in relation to the patient, the last month.
|
5 minutes
|
|
Physiological measures
Time Frame: 15 minutes
|
Blood pressure measured by blood pressure monitor, resting heart rate, and breathing frequency
|
15 minutes
|
|
Body measures
Time Frame: 5 minutes
|
Weight, length, BMI and waistline will be measured
|
5 minutes
|
|
Motion Capture
Time Frame: 60 minutes
|
Movement of the participants will be recorded with the Qualisys Motion Capture device during the movement intervention
|
60 minutes
|
|
fNIRS, EEG, and eye-tracking
Time Frame: 45 minutes
|
Cortical activity and eye movements will be measured from the patients with a combined EEG-fNIRS cap and eye-tracking glasses in stillness (baseline brain activity) and when doing conventional tasks measuring cognitive skills, emotion regulation and movement imitation
|
45 minutes
|
|
Postural stability test/balance
Time Frame: 10 minutes
|
Measuring postural sway while person is standing on a forceplate
|
10 minutes
|
|
Chair stand test
Time Frame: 3 minutes
|
Chair stand test to measure strength in the legs
|
3 minutes
|
|
Everyday activity
Time Frame: 7 days
|
Everyday activity is measured by an accelerometer which the participants will carry with them for seven days in a row to collect the amount of time spent sedentary, and active, and the intensity of the activity
|
7 days
|
|
Blood samples
Time Frame: 5 minutes
|
Blood samples including triglycerides, cholesterol, HDL, VLDL, HbA1, CRP, IL1b, IL6, TNFa, Hb, LPK, TPK, ASAT, ALAT, Natrium, Potassium and Creatinin
|
5 minutes
|
|
Interviews
Time Frame: 60 minutes
|
Qualitative semistructured interviews with 15-20 persons after the intervention.
Both participants and related parties get to share their experience of the intervention as well as eventual effects from it
|
60 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mats Eriksson, Professor, Örebro University, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 278241
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia and Related Disorders
-
Kutahya Health Sciences UniversityRecruiting
-
Anders Fink-Jensen, MD, DMSciRecruitingAlcohol Dependence | Alcoholism | Schizophrenia | Alcohol Use Disorder | Schizophrenia and Schizophrenia Spectrum Psychosis | Schizophrenia Disorders | Schizophrenia and Disorders With Psychotic Features | Alcohol Abuse/DependenceDenmark
-
Haukeland University HospitalRecruitingBipolar Disorder | Schizophrenia and Related DisordersNorway
-
University of TorontoOntario Shores Centre for Mental Health SciencesWithdrawnSchizophrenia | Schizophrenia and Related Disorders | Schizophrenia Spectrum DisorderCanada
-
University Hospital, AkershusCompletedBipolar Disorder | Schizophrenia and Related Disorders
-
The Hong Kong Polytechnic Universityhealth bureau, hong kongNot yet recruitingSchizophrenia and Related Disorders
-
Northwell HealthWinterlight LabsCompletedSchizophrenia and Related DisordersUnited States
-
National Taiwan University HospitalRecruitingSchizophrenia and Related DisordersTaiwan
-
University of BernTerminatedSchizophrenia and Related DisordersSwitzerland
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH); Columbia University; Stanford University and other collaboratorsCompleted
Clinical Trials on Creative physical training
-
Istanbul Arel UniversityEnrolling by invitationExplaining Nursing Theories Through Creative DramaTurkey
-
Prof. dr. Filip RaesResearch Foundation FlandersCompletedResilience | Mental Wellbeing | Specific Positive Memories | Specific Positive Future EventsBelgium
-
Gazi UniversityThe Scientific and Technological Research Council of TurkeyCompletedNursing | Coping | Emotional Intelligence | Creative Drama | UndergraduateTurkey (Türkiye)
-
Nantes University HospitalCompletedEmotion Management Skill | Educational Therapy | Creative and Physical ActivitiesFrance
-
Abant Izzet Baysal UniversityNot yet recruitingEducation | Nurse's Role | Mental Health LiteracyTurkey
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Compagnia di San Paolo; Scuola Holden Contemporary HumanitiesCompletedEmpathy | Well-Being, PsychologicalItaly
-
University of ConnecticutEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingCerebral Palsy | Hemiplegia | Children, OnlyUnited States
-
Ankara Yildirim Beyazıt UniversityCompleted